Table 4.
Antimicrobial Classes | Total No. of Isolates (%) | Resistance Pattern (No. of Isolates) | ||
---|---|---|---|---|
Entry (104) | Exit (144) | Entry | Exit | |
All susceptible | 26 (25.00) | 4 (2.78) | 26 | 4 |
1 | 50 (48.08) | 44 (30.56) | LIN (38) | LIN (38) |
DAP (6) | NIT (6) | |||
CIP (3) | ||||
TGC (2) | ||||
TET (1) | ||||
2 | 18 (17.31) | 55 (38.19) | DAP-LIN (11) | LIN-NIT (28) |
CIP-NIT (1) | LIN-Q/D (9) | |||
CIP-TET (1) | CIP-LIN (1) | |||
DAP-NIT (1) | DAP-NIT (7) | |||
LIN-TIG (3) | DAP-LIN (7) | |||
LIN-Q/D (1) | CIP-NIT (1) | |||
LIN-TET (1) | ||||
ERY-LIN-TYL (1) | ||||
3 | 8 (7.69) | 31 (21.53) | DAP-LIN-NIT (6) | LIN-NIT-Q/D (10) |
CIP-LIN-NIT (1) | CIP-LIN-NIT (3) | |||
DAP-LIN-TET (1) | CIP-DAP-NIT (3) | |||
CIP-NIT-TIG (1) | ||||
DAP-LIN-TET (2) | ||||
DAP-LIN-Q/D (1) | ||||
DAP-LIN-NIT (8) | ||||
NIT-STR-TET (1) | ||||
LIN-NIT-TET (1) | ||||
ERY-LIN-TIG-TYL (1) | ||||
4 | 2 (1.92) | 9 (6.25) | CIP-DAP-LIN-Q/D (1) | DAP-LIN-NIT-TET (1) |
ERY-LIN-Q/D-TET-TYL (1) | KAN-LIN-NIT-Q/D (2) | |||
DAP-ERY-LIN-NIT (1) | ||||
CIP-DAP-LIN-NIT (1) | ||||
LIN-NIT-Q/D-TET (1) | ||||
ERY-LIN-Q/D-TET-TYL (2) | ||||
ERY-LIN-NIT-TET-TYL (1) | ||||
5 | 1 (0.69) | CIP-DAP-LIN-NIT-Q/D (1) | ||
Non-MDR | 68 (65.4) | 99 (68.8) | ||
MDR | 11 (10.6) | 41 (28.5) | ||
Resistance | 79 (76.0) | 140 (96.3) |
CIP, Ciprofloxacin; DAP, Daptomycin; ERY, Erythromycin; KAN, Kanamycin; LIN, Lincomycin; NIT, Nitrofurantoin; Q/D, Quinupristin/dalfopristin; STR, Streptomycin; TET, Tetracycline; TIG, Tigecycline; TYL, Tylosine tartrate.